Integral Diagnostics Ltd
ASX:IDX

Watchlist Manager
Integral Diagnostics Ltd Logo
Integral Diagnostics Ltd
ASX:IDX
Watchlist
Price: 2.465 AUD 0.61%
Market Cap: 919.3m AUD

Intrinsic Value

The intrinsic value of one IDX stock under the Base Case scenario is 4.795 AUD. Compared to the current market price of 2.465 AUD, Integral Diagnostics Ltd is Undervalued by 49%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IDX Intrinsic Value
4.795 AUD
Undervaluation 49%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Integral Diagnostics Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about IDX?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is IDX valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Integral Diagnostics Ltd.

Explain Valuation
Compare IDX to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Heightened cost pressures from radiologist staffing shortages and wage inflation could squeeze margins, especially if Integral Diagnostics struggles to recruit and retain top talent across its expanding network.

Regulatory changes or tighter government reimbursement policies in Australia and New Zealand may constrain revenue growth and reduce profitability, given the company’s reliance on public health funding for diagnostic services.

Integration risks from ongoing acquisitions could lead to operational inefficiencies, eroding economies of scale and delaying the anticipated benefits of expansion.

Bull Theses

Growing demand for advanced imaging services, underpinned by an aging population and higher chronic disease prevalence, should drive sustained growth for Integral Diagnostics’ broad service offering.

A robust acquisition pipeline and successful integration of newly acquired clinics could strengthen the company’s geographic footprint and enhance bargaining power with payers and suppliers.

Ongoing investment in cutting-edge imaging technology and digital platforms may boost clinical efficiency, attract high-caliber radiologists, and create a competitive edge in specialized diagnostic services.

Show More Less
How do you feel about IDX?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Integral Diagnostics Ltd

Current Assets 95.3m
Cash & Short-Term Investments 52.1m
Receivables 28.5m
Other Current Assets 14.7m
Non-Current Assets 1.3B
Long-Term Investments 5k
PP&E 468.8m
Intangibles 862.4m
Current Liabilities 140.7m
Accounts Payable 64.5m
Other Current Liabilities 76.2m
Non-Current Liabilities 592.8m
Long-Term Debt 564.7m
Other Non-Current Liabilities 28.1m
Efficiency

Free Cash Flow Analysis
Integral Diagnostics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Integral Diagnostics Ltd

Revenue
628m AUD
Cost of Revenue
-28.1m AUD
Gross Profit
599.8m AUD
Operating Expenses
-541.6m AUD
Operating Income
58.3m AUD
Other Expenses
-53.6m AUD
Net Income
4.7m AUD
Fundamental Scores

IDX Profitability Score
Profitability Due Diligence

Integral Diagnostics Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Gross Margin is Increasing
Low 3Y Average Operating Margin
45/100
Profitability
Score

Integral Diagnostics Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

IDX Solvency Score
Solvency Due Diligence

Integral Diagnostics Ltd's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Low Altman Z-Score
29/100
Solvency
Score

Integral Diagnostics Ltd's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IDX Price Targets Summary
Integral Diagnostics Ltd

Wall Street analysts forecast IDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDX is 3.498 AUD with a low forecast of 3.232 AUD and a high forecast of 4.2 AUD.

Lowest
Price Target
3.232 AUD
31% Upside
Average
Price Target
3.498 AUD
42% Upside
Highest
Price Target
4.2 AUD
70% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for IDX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one IDX stock?

The intrinsic value of one IDX stock under the Base Case scenario is 4.795 AUD.

Is IDX stock undervalued or overvalued?

Compared to the current market price of 2.465 AUD, Integral Diagnostics Ltd is Undervalued by 49%.

Back to Top